These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 17473209

  • 1. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens.
    Sabnis G, Goloubeva O, Jelovac D, Schayowitz A, Brodie A.
    Clin Cancer Res; 2007 May 01; 13(9):2751-7. PubMed ID: 17473209
    [Abstract] [Full Text] [Related]

  • 2. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ, Jelovac D, Thiantanawat A, Brodie AM.
    Clin Cancer Res; 2002 Jul 01; 8(7):2378-88. PubMed ID: 12114443
    [Abstract] [Full Text] [Related]

  • 3. Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model.
    Jelovac D, Macedo L, Goloubeva OG, Handratta V, Brodie AM.
    Cancer Res; 2005 Jun 15; 65(12):5439-44. PubMed ID: 15958593
    [Abstract] [Full Text] [Related]

  • 4. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
    Belosay A, Brodie AM, Njar VC.
    Cancer Res; 2006 Dec 01; 66(23):11485-93. PubMed ID: 17145897
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL, Rasmussen BB, Lykkesfeldt AE, Møller S, Ejlertsen B, Mouridsen HT.
    Acta Oncol; 2009 Dec 01; 48(4):522-31. PubMed ID: 19173092
    [Abstract] [Full Text] [Related]

  • 10. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.
    Clin Cancer Res; 2000 May 01; 6(5):2028-36. PubMed ID: 10815929
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation.
    Sabnis GJ, Jelovac D, Long B, Brodie A.
    Cancer Res; 2005 May 01; 65(9):3903-10. PubMed ID: 15867390
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The intratumoral aromatase model: studies with aromatase inhibitors and antiestrogens.
    Brodie AH, Jelovac D, Long B.
    J Steroid Biochem Mol Biol; 2003 Sep 01; 86(3-5):283-8. PubMed ID: 14623522
    [Abstract] [Full Text] [Related]

  • 17. Aromatase inhibitors: rationale for use following antiestrogen therapy.
    Yue W, Santen RJ.
    Semin Oncol; 1996 Aug 01; 23(4 Suppl 9):21-7. PubMed ID: 8824461
    [Abstract] [Full Text] [Related]

  • 18. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC, O'Regan RM, Gajdos C, Robinson SP, Bentrem D, De Los Reyes A, Jordan VC.
    Clin Cancer Res; 2002 Jun 01; 8(6):1995-2001. PubMed ID: 12060645
    [Abstract] [Full Text] [Related]

  • 19. Aromatase inhibitors and breast cancer.
    Macedo LF, Sabnis G, Brodie A.
    Ann N Y Acad Sci; 2009 Feb 01; 1155():162-73. PubMed ID: 19250202
    [Abstract] [Full Text] [Related]

  • 20. New approaches to reverse resistance to hormonal therapy in human breast cancer.
    Weinberg OK, Marquez-Garban DC, Pietras RJ.
    Drug Resist Updat; 2005 Aug 01; 8(4):219-33. PubMed ID: 16054421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.